Conference Description

April 28-29, 2007
Crowne Plaza Hotel at Historic Union Station
123 W. Louisiana Street
Indianapolis, IN
317-631-2221

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 10.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:

This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. appreciate that given its favorable risk to benefit ratio, the more widespread and appropriate aggressive management of patients with statins will confer statistically significant and clinically important reductions in myocardial infarction, stroke, and deaths from cardiovascular disease
2. discuss the vascular pathophysiology and biochemical origins of vascular disease in patients with type 2 diabetes; review recent outcomes trials (positive and negative) for reducing cardiovascular risk in patients with type 2 diabetes (FIELD, CARDS, PROactive, CHICAGO), and utilize current treatment options to more effectively reduce cardiovascular risk in patients with hyperglycemia
3. review glycemic and cardiovascular outcomes from insulin trials in type 2 diabetes, and optimize glycemic control with insulin in type 2 diabetes while minimizing weight gain and hypoglycemia
4. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predomi - nant irritable bowel syndrome and chronic constipation
5. recognize common skin problems like Acne and Rosacea and, after understanding their pathogenesis, offer effective, state of the art treatment options
6. identify the most pertinent adverse events seen in the Women’s Health Initiative and advise patients on the risks and benefits of traditional, nontraditional, and alternative medical interventions for addressing menopausal symptoms
7. recognize the underlying pathophysiology of BPH, utilize the AUA scoring system and choose appropriate pharmacotherapy and surgical interventions for BPH
8. understand the United States Public Health Services Guidelines on Tobacco Use and Dependence Treatment; appreciate the effect of even brief, repeated, health care professional counseling, and effectively utilize currently approved medications for smoking cessation
9. identify the risk factors for Insomnia, understand the principles of sleep restriction, and more appropriately utilize currently available hypnotic therapies
10. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life

Agenda:
Saturday, April 28, 2007

7:20-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Gregg Sherman, MD
8:10-9:10		Update on Statins in the Treatment and Prevention of Cardiovascular Disease: Clinical and Public Health Challenges Charles Hennekens, MD
9:10-10:10		Type 2 Diabetes: A Metabolic Vasculopathy with Hyperglycemia Patrick J. Boyle, MD
10:10-10:30		Break
10:30-11:30		Insulin Therapy in Type 2 Diabetes – Who, When, and How Patrick J. Boyle, MD
11:30-12:30		Evolving Concepts in GI Motility Disorders: IBS-Constipation and Chronic Constipation Brooks D. Cash, MD, FACP, FACG
12:30-1:30		Lunch
1:30-2:30		Acne and Rosacea Update Brian Berman, MD, PhD
2:30-3:30		Insomnia: Who Gets It, and What Can be Done About It? Barbara Phillips, MD, MSPH, FCCP
3:30-3:50		Break
3:50-4:50		Update on Restless Leg Syndrome Barbara Phillips, MD, MSPH, FCCP
4:50-5:00		Post-Assessment

Sunday, April 29, 2007

Faculty:
Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
The University of Miami School of Medicine

Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico

Brooks D. Cash, MD, FACP, FACG
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine, USUHS
National Naval Medical Center
Bethesda, MD

Charles Hennekens, MD
Co-Director of Cardiovascular Research at MSMC-MHI
Professor of Medicine & Epidemiology and Public Health at
the University of Miami School of Medicine

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainseville, FL

Theodore W. Marcy, MD, MPH
Associate Professor of Medicine
University of Vermont College of Medicine

Barbara Phillips, MD, MSPH, FCCP
Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
University of KY College of Medicine

Ross Rames, MD
Associate Professor of Urology
Division of Urodynamics and Continence
Medical University of South Carolina

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 10.0 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 10 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 12.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Boehringer Ingelheim, Collagenex, Merck, Novo nordisk, Pfizerr, sanofi-aventis, Takeda, Wyeth.